These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 14320583)
1. FDA ACTIVITIES. RANKIN WB Mil Med; 1965 Aug; 130():803-6. PubMed ID: 14320583 [No Abstract] [Full Text] [Related]
2. PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961. KELSEY FO Am J Public Health Nations Health; 1965 May; 55(5):703-7. PubMed ID: 14287841 [No Abstract] [Full Text] [Related]
3. THE RELATIONSHIP OF THE FOOD AND DRUG ADMINISTRATION TO THE PRACTICE OF MEDICINE AND THE AMINOPYRINE-DIPYRONE PROBLEM. SADUSK JF J New Drugs; 1965; 5(1):57-62. PubMed ID: 14283069 [No Abstract] [Full Text] [Related]
4. FEDERAL HAZARDOUS SUBSTANCES LABELING ACT. LIGON EW Arch Environ Health; 1965 Apr; 10():596-8. PubMed ID: 14254886 [No Abstract] [Full Text] [Related]
5. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
6. PESTICIDE REGULATORY ACTIVITIES OF THE FOOD AND DRUG ADMINISTRATION. ROE S Am J Public Health Nations Health; 1965 Jul; 55(Suppl 7):SUPPL:36-7. PubMed ID: 14312326 [No Abstract] [Full Text] [Related]
7. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS. LARRICK GP J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105 [No Abstract] [Full Text] [Related]
8. THE FOOD AND DRUG ADMINISTRATION AND THE PREVENTION OF DRUG EMBRYOPATHY. ELLENHORN MJ J New Drugs; 1964; 4(1):12-20. PubMed ID: 14157080 [No Abstract] [Full Text] [Related]
9. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ Am J Pharm Sci Support Public Health; 1964; 136():114-27. PubMed ID: 14167236 [No Abstract] [Full Text] [Related]
10. WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938. LARRICK GP J New Drugs; 1964; 4(2):105-10. PubMed ID: 14197104 [No Abstract] [Full Text] [Related]
11. THE FOOD AND DRUG ADMINISTRATION'S VIEW OF INVESTIGATIONAL DRUGS. MEYERS EL Am J Pharm Sci Support Public Health; 1963 Jun; 135():219-29. PubMed ID: 14046043 [No Abstract] [Full Text] [Related]
12. Scientific evidence and common sense as a basis for food-packaging regulations. Frawley JP Food Cosmet Toxicol; 1967 Aug; 5(3):293-308. PubMed ID: 4861454 [No Abstract] [Full Text] [Related]
13. LEGAL AND ETHICAL ASPECTS OF EXPERIMENTAL DRUG DISTRIBUTION AND RETRIEVAL. BALLARD RW; COOPER WA; WILLIG SH J New Drugs; 1965; 5(2):72-7. PubMed ID: 14315153 [No Abstract] [Full Text] [Related]
14. FDA tells senators of doctors who fake data in clinical drug trials. Holden C Science; 1979 Oct; 206(4417):423-3. PubMed ID: 504984 [No Abstract] [Full Text] [Related]
15. Dietary supplements--regulatory issues and implications for public health. Denham BE JAMA; 2011 Jul; 306(4):428-9. PubMed ID: 21730229 [No Abstract] [Full Text] [Related]
16. Progress under the Kefauver-Harris Drug Amendments. Rankin WB Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717 [No Abstract] [Full Text] [Related]
17. The Food and Drug Administration Amendments Act and postmarketing commitments. Fain K; Daubresse M; Alexander GC JAMA; 2013 Jul; 310(2):202-4. PubMed ID: 23839755 [No Abstract] [Full Text] [Related]
18. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]
19. The Food and Drug Administration and freedom of information. Radzius JR Leg Aspects Med Pract; 1978 Jan; 6(1):52-4. PubMed ID: 750805 [No Abstract] [Full Text] [Related]
20. An overview from the United States. Besselaar GH; Tempero KF Clin Pharmacol Ther; 1974 Sep; 16(3):620-4. PubMed ID: 4411989 [No Abstract] [Full Text] [Related] [Next] [New Search]